N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide
Modify Date: 2024-01-15 17:04:29
![N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide Structure](https://image.chemsrc.com/caspic/075/630125-92-7.png)
N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide structure
|
Common Name | N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide | ||
|---|---|---|---|---|
| CAS Number | 630125-92-7 | Molecular Weight | 383.33200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H19F6N3O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C16H19F6N3O |
|---|---|
| Molecular Weight | 383.33200 |
| Exact Mass | 383.14300 |
| PSA | 39.07000 |
| LogP | 3.86900 |
|
~%
N-[4-[(4-ethylp... CAS#:630125-92-7 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2005/51366 A2, 2005 ; Location in patent: Page/Page column 102 ; WO 2005/051366 A2 |
![N-[4-(bromomethyl)-3-(trifluoromethyl)phenyl]-2,2,2-trifluoroacetamide structure](https://image.chemsrc.com/caspic/206/630125-84-7.png)
| 2,2,2-trifluoro-N-(4-(4-ethylpiperazin-1-ylmethyl)-3-trifluoromethyl-phenyl)acetamide |
| ACETAMIDE,N-[4-[(4-ETHYL-1-PIPERAZINYL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL]-2,2,2-TRIFLUORO |
| N-[4-(4-ethyl-piperazin-1-ylmethyl)-3-trifluoromethyl-phenyl]-2,2,2-trifluoro-acetamide |